OneSource Specialty Pharma Limited, previously known as Stelis Biopharma, has received equity commitments amounting to INR 8,010 million (approximately USD 95 million) from prominent institutional investors, thereby positioning the company at a pre-money valuation of USD 1.65 billion. This strategic financial endorsement, led by HBM Healthcare Investments along with substantial contributions from WhiteOak Capital, Param […]
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received the United States Food & Drug Administration (USFDA) approval for Gabapentin Tablets USP, 600 mg and 800 mg. This approval marks a significant milestone for Strides, […]
Strides Pharma Science Limited (Strides) has achieved a significant milestone by announcing the United States Food & Drug Administration (USFDA) approval of Icosapent Ethyl Capsules 0.5 gram and 1 gram. This approval comes through its wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore. The newly approved product seamlessly integrates into Strides’ portfolio of authorized […]
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (FDA) for Ibuprofen Oral Suspension USP, 50 mg/1.25 mL (40 mg/mL) (OTC). The pain drug product from Strides Pharma is the generic of GlaxoSmithKline Consumer Healthcare Holdings (US)’s […]
Strides Pharma Science Limited said that its Singapore-based stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited has secured approval for Colchicine Tablets USP, 0.6 mg from the US Food & Drug Administration (USFDA). Colchicine Tablets USP, 0.6 mg is bioequivalent and therapeutically equivalent to Colcrys Tablets, 0.6 mg, of Takeda Pharmaceuticals U.S.A. Colchicine tablets […]
Strides Pharma Science Limited said that Strides Pharma Global Pte. Limited, Singapore, its step-down fully-owned subsidiary, has secured approval for Oseltamivir Phosphate for Oral Suspension,6 mg/mL from the US Food & Drug Administration (FDA). The drug is bioequivalent and therapeutically equivalent to Tamiflu for Oral Suspension, 6 mg/mL, of Hoffmann-La Roche (Roche). As per IQVIA […]
Strides Pharma Science Limited will acquire the manufacturing facility of Endo International in Chestnut Ridge, New York along with a portfolio of abbreviated new drug applications (ANDAs) for nearly $24 million. The Indian pharma company said that the deal will help it further strengthen its footprint in the US, courtesy of the multi dosage facility […]
Strides Pharma Science Limited has entered into a partnership with Taiwan-based TLC to distribute the latter’s liposomal amphotericin B drug in India for the treatment of Black Fungus in Covid-19 patients under the AmphoTLC brand. The agreement between the parties follows the approval of TLC’s new drug application (NDA) of Amphotericin B Liposome for Injection […]
